Yinon Levy

885 total citations
30 papers, 461 citations indexed

About

Yinon Levy is a scholar working on Genetics, Molecular Biology and Parasitology. According to data from OpenAlex, Yinon Levy has authored 30 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 14 papers in Molecular Biology and 9 papers in Parasitology. Recurrent topics in Yinon Levy's work include Yersinia bacterium, plague, ectoparasites research (23 papers), Bacillus and Francisella bacterial research (12 papers) and Vector-borne infectious diseases (9 papers). Yinon Levy is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (23 papers), Bacillus and Francisella bacterial research (12 papers) and Vector-borne infectious diseases (9 papers). Yinon Levy collaborates with scholars based in Israel and United States. Yinon Levy's co-authors include Emanuelle Mamroud, Ayelet Zauberman, Moshe Aftalion, Avital Tidhar, David Gur, Yaron Vagima, Avigdor Shafferman, Yehuda Flashner, Batya Cohen and Menachem Rubinstein and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Yinon Levy

29 papers receiving 455 citations

Peers

Yinon Levy
Lawton K. Chung United States
Jovanka T. Koo United States
Svetlana Senina United States
Kristin J. Pederson United States
Sonja Preger Germany
Elizabeth A. Rucks United States
Anne McIntosh United Kingdom
Yinon Levy
Citations per year, relative to Yinon Levy Yinon Levy (= 1×) peers Avital Tidhar

Countries citing papers authored by Yinon Levy

Since Specialization
Citations

This map shows the geographic impact of Yinon Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinon Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinon Levy more than expected).

Fields of papers citing papers by Yinon Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinon Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinon Levy. The network helps show where Yinon Levy may publish in the future.

Co-authorship network of co-authors of Yinon Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Yinon Levy. A scholar is included among the top collaborators of Yinon Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinon Levy. Yinon Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elia, Uri, Yinon Levy, Hagai Cohen, et al.. (2025). Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague. Advanced Science. 12(26). e2501286–e2501286. 3 indexed citations
2.
Kon, Edo, Yinon Levy, Uri Elia, et al.. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 9(10). eadg1036–eadg1036. 61 indexed citations
3.
Aftalion, Moshe, Avital Tidhar, Yaron Vagima, et al.. (2023). Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens. Vaccines. 11(3). 581–581. 7 indexed citations
4.
Levy, Yinon, Ron Alcalay, Anat Zvi, et al.. (2022). Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses. Vaccines. 10(2). 251–251. 4 indexed citations
5.
Vagima, Yaron, David Gur, Moshe Aftalion, et al.. (2022). Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague. Viruses. 14(4). 688–688. 11 indexed citations
6.
Rosen, Osnat, Arik Makovitzki, Lilach Cherry, et al.. (2022). SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine. Journal of Virological Methods. 303. 114498–114498. 3 indexed citations
7.
Israeli, Ofir, Inbar Cohen-Gihon, Moshe Aftalion, et al.. (2021). Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection. Microorganisms. 9(10). 2166–2166. 1 indexed citations
8.
Mechaly, Adva, Einat B. Vitner, Yinon Levy, et al.. (2021). Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection. Pathogens. 10(3). 285–285. 3 indexed citations
9.
Vagima, Yaron, David Gur, Noam Erez, et al.. (2020). Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments. Scientific Reports. 10(1). 19116–19116. 4 indexed citations
10.
Tidhar, Avital, Yinon Levy, Ayelet Zauberman, et al.. (2019). Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system. PLoS neglected tropical diseases. 13(6). e0007449–e0007449. 8 indexed citations
11.
Aftalion, Moshe, David Gur, Yinon Levy, et al.. (2019). Development of Improved Devices for Handling and Restraining Experimental Laboratory Mice. Applied Biosafety. 25(1). 53–58.
12.
Vagima, Yaron, Yinon Levy, & Emanuelle Mamroud. (2019). Monitoring of Neutrophil Recruitment to Mice Lungs During Pneumonic Plague. Methods in molecular biology. 2010. 141–150. 2 indexed citations
13.
Levy, Yinon, Yaron Vagima, Avital Tidhar, et al.. (2018). Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague. npj Vaccines. 3(1). 52–52. 19 indexed citations
14.
Gur, David, Itai Glinert, Moshe Aftalion, et al.. (2018). Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model. Frontiers in Microbiology. 9. 741–741. 15 indexed citations
15.
Vagima, Yaron, Ayelet Zauberman, Yinon Levy, et al.. (2015). Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague. PLoS Pathogens. 11(5). e1004893–e1004893. 44 indexed citations
16.
Zauberman, Ayelet, Yehuda Flashner, Yinon Levy, et al.. (2013). YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. PLoS ONE. 8(12). e83560–e83560. 9 indexed citations
17.
Vagima, Yaron, Yinon Levy, David Gur, et al.. (2012). Early sensing of Yersinia pestis airway infection by bone marrow cells. Frontiers in Cellular and Infection Microbiology. 2. 143–143. 13 indexed citations
18.
Levy, Yinon, Yehuda Flashner, Avital Tidhar, et al.. (2011). T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Vaccine. 29(40). 6866–6873. 24 indexed citations
19.
Zauberman, Ayelet, Avital Tidhar, Yinon Levy, et al.. (2009). Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague. PLoS ONE. 4(6). e5938–e5938. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026